AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
IDEAYA Biosciences, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00CTZ4D92
34.71▼ 1.41 (-3.90%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
36.12
Day's Range
34.54 – 36.35
52-Week Range
26.81 – 42.68
Volume
1.1M
Avg Volume
855.6K
Share Statistics
Shares Outstanding
Employees
145
Exchange
XNAS
Listed
2019-05-23
Share count as of July 31, 2026

IDEAYA Biosciences, Inc. Common Stock (IDYA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about IDEAYA Biosciences, Inc. Common Stock (IDYA)
What is IDEAYA Biosciences, Inc. Common Stock's Market Cap?
IDEAYA Biosciences, Inc. Common Stock's Market Cap is $3.3B, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's Enterprise Value?
IDEAYA Biosciences, Inc. Common Stock's Enterprise Value is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's Price / Sales?
IDEAYA Biosciences, Inc. Common Stock's Price / Sales is 14.3×, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's EV / Revenue?
IDEAYA Biosciences, Inc. Common Stock's EV / Revenue is 10.8×, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's EV / EBITDA?
IDEAYA Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's Revenue (TTM)?
IDEAYA Biosciences, Inc. Common Stock's Revenue (TTM) is $234.1M, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's Net Income (TTM)?
IDEAYA Biosciences, Inc. Common Stock's Net Income (TTM) is -$175.0M, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's EBITDA?
IDEAYA Biosciences, Inc. Common Stock's EBITDA is -$214.2M, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's Diluted EPS (TTM)?
IDEAYA Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -1.81, based on as-reported figures from SEC (XBRL) filings.
What is IDEAYA Biosciences, Inc. Common Stock's EBITDA Margin?
IDEAYA Biosciences, Inc. Common Stock's EBITDA Margin is -91.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IDYAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Collaboration revenue
YoY growth————
Operating expenses
Research and development
General and administrative
Total operating expenses
% of revenue1480.7%1754.6%969.5%47.8%
Loss from operations
% of revenue-1380.7%-1654.6%-869.5%52.2%
Interest income and other income, net
Net loss
% of revenue-1269.6%-1502.1%-765.7%57.4%
Net loss per common share, basic
Net loss per common share, diluted